Filtered By:
Procedure: Gastroschisis Repair
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 67467 results found since Jan 2013.
Implantable medical devices for tendon and ligament repair: a review of patents and commercial products
Expert Rev Med Devices. 2022 Oct 31. doi: 10.1080/17434440.2022.2142557. Online ahead of print.ABSTRACTINTRODUCTION: Tendon and ligament injuries are a frequent and debilitating issue that affects many patients worldwide. The predominant solution is the suture thread, which is not without potential side effects and limitations. Implantable medical devices have gained more attention as an alternative approach. However, due to the many challenges of the inner body environment (limited available space, chemically aggressive environment, etc), the development of suitable devices is not exempt from practical and technical diffi...
Source: Expert Review of Medical Devices - October 31, 2022 Category: Medical Devices Authors: Marco Civera Ester Devietti Goggia Matteo De Ros Vito Burgio Federica Bergamin Mariana Rodriguez Reinoso Cecilia Surace Source Type: research
Experiences of medical practitioners in the Australian Defence Force on live tissue trauma training
Conclusion
In contrast to published research, live tissue training was thought by participants to possess characteristics that are not yet replicable using alternative learning aids. The experienced positive values of live tissue training should inform the decision to move towards non-animal alternatives.
Source: Journal of the Royal Army Medical Corps - March 23, 2023 Category: General Medicine Authors: Mahoney, A., Reade, M. C., Moffat, M. Tags: Original research Source Type: research
Mussel-Inspired Glue for Medical Use
(Ivanhoe Newswire) – Mussels are nature's glue. They can adhere to all inorganic and organic surfaces while sustaining their bonds in saltwater. Now, researchers are exploring ways to mimic mussel adhesive proteins for three medical uses: sealants for fetal membrane repair, self-setting antibacterial hydrogels, and polymers for cancer drug delivery and thermal destruction of cancer cells.
Source: Medical Headlines From Ivanhoe.com - February 18, 2013 Category: Consumer Health News Source Type: news
First U.S. patients treated with Aorfix flexible aortic stent graft
Lombard Medical Technologies PLC, has announced that the first U.S. patients have been successfully treated with Aorfix™, the Group's flexible stent graft for the endovascular repair of abdominal aortic aneurysms (AAAs). Aorfix was approved by the FDA for commercial sale in the U.S. in February 2013. The approval included a label indication for the treatment of patients with angulations at the neck of the aneurysm from 0 to 90 degrees...
Source: Health News from Medical News Today - August 28, 2013 Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news
Insightra Medical Launches Freedom Inguinal Hernia Repair System Study
Insightra Medical, Inc. announced today the commencement of patient enrollment in the company’s Freedom Inguinal Hernia Repair System Study that is led by Dr. Karl LeBlanc of Our Lady of the Lake...(PRWeb March 12, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11649309.htm
Source: PRWeb: Medical Pharmaceuticals - March 13, 2014 Category: Pharmaceuticals Source Type: news
Dallen Medical Receives FDA Clearance For Tensyn Band For AC/CC Joint Stabilization
Dallen Medical Inc., an innovator in bone fixation and repair, recently announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Tensyn Band for acromioclavicular (AC) joint and coracoacromial (CC) ligament repair in shoulder separation
Source: Medical Design Online News - October 30, 2014 Category: Medical Equipment Source Type: news
Medtronic reveals stake in Arsenal Medical
Medtronic (NYSE:MDT) yesterday said it took out a stake with an option to buy on Arsenal Medical and its hemostatic foam.
Arsenals is developing the foam and a delivery system that are designed to reduce the chance of endoleaks after the placement of a stent graft to treat an abdominal aortic aneurysm.
Financial terms of the investment were not disclosed, but Medtronic said the deal includes an option to acquire Arsenal “after the company achieves certain milestones.”
Earlier this month, Arsenal and sister company480 Biomedical raised a collective $26 million from a syndicate of backers that included R...
Source: Mass Device - June 18, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Business/Financial News Funding Roundup Stent Grafts Arsenal Medical medtronic Source Type: news
Silk Road Medical raises $57 million
Silk Road Medical today said it reeled in a $57 million equity-and-debt round from a group of new and existing backers.
Sunnyvale, Calif.-based Silk Road, which makes the Enroute transcarotid artery stent and neuroprotection system, said CRG led the debt round and participated in the equity portion, joined by prior investors Warburg Pincus and The Vertical Group.
“The strength of this financing is a testament to the large opportunity we have to solve unmet clinical needs and lead the next endovascular revolution with TCAR,” CEO Erica Rogers said in prepared remarks. “Our proprietary advances in tempo...
Source: Mass Device - October 20, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Stents Vascular Silk Road Medical Inc. Stroke Source Type: news
St. Jude Medical rejiggers sales reporting
St. Jude Medical (NYSE:STJ) said today that it plans to rejigger the way it reports its sales to better reflect its focus in managing the business, beginning this year.
Little Canada, Minn.-based St. Jude, which saw its share price slide today after missing forecasts for its 4th-quarter sales, said it’s focus is shifting to 5 key key areas: Heart failure; atrial fibrillation; neuromodulation; cardiovascular disease; and traditional cardiac rhythm management.
The heart failure segment covers bi-ventricular CRT pacemakers and ICDs, the ventricular assist devices acquired along with Thoratec last October, and the...
Source: Mass Device - January 13, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular MassDevice Earnings Roundup Neuromodulation/Neurostimulation Wall Street Beat St. Jude Medical Source Type: news
CryoLife deals Hero graft to Merit Medical for $19m
CryoLife Inc. (NYSE:CRY) said today that it dealt its Hero hemodialysis access graft to Merit Medical (NSDQ:MMSI) for $18.5 million in cash.
The Hero graft put up $7.5 million in sales for CryoLife last year, the Atlanta-based company said. The deal calls for CryoLife to continue manufacturing the device for up to 6 months, when Salt Lake City-based Merit will take over production.
“The recent acquisition of On-X Life Technologies strengthened our strategic focus on aortic and mitral valve repair and replacement surgery. The transaction more than doubled our U.S. cardiac surgery sales force. The sale of the Hero gr...
Source: Mass Device - February 4, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Dialysis Mergers & Acquisitions Wall Street Beat CryoLife Merit Medical Systems Inc. Source Type: news
FDA Seeks Industry Feedback On Refurbished Medical Devices
The U.S. Food and Drug Administration (FDA) is soliciting information from companies and third-party entities who refurbish, recondition, rebuild, remarket, remanufacture, service, and repair medical devices.
Source: Medical Design Online News - March 7, 2016 Category: Medical Equipment Source Type: news
In-situ medical simulation for pre-implementation testing of clinical service in a regional hospital in Hong Kong.
This article describes our experience with the use of simulation in pre-implementation testing of a clinical process or service. We found the method useful and would recommend it to others.
PMID: 28775221 [PubMed - in process]
Source: Hong Kong Medical Journal - August 5, 2017 Category: General Medicine Tags: Hong Kong Med J Source Type: research
Initial experience with percutaneous edge-to-edge transcatheter mitral valve repair in a tertiary medical center in Taiwan
Conclusion Trans-catheter edge-to-edge mitral valve repairs are safe and effective in Asians with symptomatic SMR, regarding the improvements of clinical symptoms and exercise capacities. MitraClips is also associated with reverse remodeling of pulmonary hypertension and left ventricular size in patients with SMR.
Source: Journal of the Chinese Medical Association - December 29, 2017 Category: General Medicine Source Type: research
Medical News Today: World first: Doctors use 'reprogrammed' stem cells to repair cornea
In a groundbreaking procedure, surgeons have successfully repaired a human cornea using 'reprogrammed' cells from the patient's skin.
Source: Health News from Medical News Today - September 6, 2019 Category: Consumer Health News Tags: Medical Innovation Source Type: news
